Azathioprine: Association with therapy-related myelodysplastic syndrome and acute myeloid leukemia

Journal of Rheumatology

Volumn 37, Issue 3, 2010, Pages 485-490

  Kwong, Yok Lam ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Acute myeloid leukemia; Azathioprine; Cytogenetics; Myelodysplastic syndrome

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GOLD; LEVAMISOLE; PENICILLAMINE; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNE HEPATITIS; CARDIAC GRAFT REJECTION; CHROMOSOME 11Q; CHROMOSOME DELETION; CHROMOSOME DELETION 5; CHROMOSOME DELETION 7; CHROMOSOME REARRANGEMENT; CROHN DISEASE; CYTOPENIA; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; HYPEREOSINOPHILIA; KARYOTYPING; KIDNEY GRAFT REJECTION; LIVER GRAFT REJECTION; LUNG GRAFT REJECTION; MONOSOMY 7; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; POLYMYOSITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT OUTCOME; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; AUTOIMMUNE DISEASES; AZATHIOPRINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 77949689666     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090834     Document Type: Review

References (50)

1. Murray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963;268:1315-23.
2. Moens C, Brocteur J. Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study. Acta Rheumatol Scand 1965;11:212-20.
3. Bouroncle BA, Doan CA. Refractory idiopathic thrombocytopenic purpura treated with azathioprine. N Engl J Med 1966;275:630-5.
4. Brooke BN, Hoffmann DC, Swarbrick ET. Azathioprine for Crohn's disease. Lancet 1969;2:612-4.
5. Theodor E, Gilon E, Waks U. Treatment of ulcerative colitis with azathioprine. Br Med J 1968;4:741-3.
6. Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol 2008;255:1449-63.
7. Karran P. Thiopurines, DNA damage, DNA repair and therapy-related cancer. Br Med Bull 2006;79-80:153-70.
8. Chalmers AH, Knight PR, Atkinson MR. Conversion of azathioprine into mercaptopurine and mercaptoimidazole derivatives in vitro and during immunosuppressive therapy. Aust J Exp Biol Med Sci 1967;45:681-91.
9. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf 1996;14:406-23.
10. Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215-9.
11. Bastida G, Nos P, Aguas M, Beltrán B, Rubín A, Dasí F, et al. Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;22:775-82.
12. International Agency for Research on Cancer (IARC). Summaries & Evaluations: Azathioprine. [Internet. Accessed December 10, 2009.] Available from: http://www.inchem.org/documents/iarc/suppl7/azathioprine.html
13. Wong G, Chapman JR. Cancers after renal transplantation. Transplant Rev 2008;22:141-9.
14. Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005;105:3802-11.
15. Cobau CD, Sheon RP, Kirsner AB. Immunosuppressive drugs and acute leukemia. Ann Intern Med 1973;79:131-2.
16. Silvergleid AJ, Schrier SL. Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases. Am J Med 1974;57:885-8.
17. Seidenfeld AM, Smythe HA, Ogryzlo MA, Urowitz MB, Dotten DA. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. J Rheumatol 1976;3:295-304.
18. Sheil AG. Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc 1977;9:1133-6.
19. Alexson E, Brandt KD. Acute leukemia after azathioprine treatment of connective tissue disease. Am J Med Sci 1977;273:335-40.
20. Gilmore IT, Holden G, Rodan KS. Acute leukaemia during azathioprine therapy. Postgrad Med J 1977;53:173-4.
21. Sloan GM, Cole P, Wilson RE. Risk indicators of de novo malignancy in renal transplant recipients. Transplant Proc 1977;9:1129-32.
22. Ellerton JA, deVeber GA, Baker MA. Erythroleukemia in a renal transplant recipient. Cancer 1979;43:1924-6.
23. Grünwald HW, Rosner F. Acute leukemia and immunosuppressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. Arch Intern Med 1979;139:461-6.
24. Vismans JJ, Briët E, Meijer K, den Ottolander GJ. Azathioprine and subacute myelomonocytic leukemia. Acta Med Scand 1980;207:315-9.
25. Hoy WE, Packman CH, Freeman RB. Evolution of acute leukemia in a renal transplant patient - ? Relationship to azathioprine. Transplantation 1982;33:331-3.
26. Ihle BU, Constable J, Gordon S, Mahony JF. Myelodysplasia in cadaver renal allografts: a report of four cases. Am J Kidney Dis 1985;5:251-7.
27. Vandenberghe EA, Mecucci C, Delannoy A, van den Berghe H. Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome. Cancer Genet Cytogenet 1990;48:49-52.
28. Krishnan K, Adams P, Silveira S, Sheldon S, Dabich L. Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis. Clin Lab Haematol 1994;16:285-9.
29. Mok CC, Kwong YL, Lau CS. Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis. Ann Rheum Dis 1995;54:155-6.
30. Renneboog B, Hansen V, Heimann P, De Mulder A, Jannsen F, Ferster A. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 1996;92:696-8.
31. Subar M, Gucalp R, Benstein J, Williams G, Wiernik PH. Acute leukaemia following renal transplantation. Med Oncol 1996;13:9-13.
32. Gorschlüter M, Glasmacher A, Risse F, Klein B, Klehr HU, Mezger J. Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant 1997;12:593-5.
33. Kwong YL, Au WY, Liang RH. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with -7/7q-. Cancer Genet Cytogenet 1998;104:94-7.
34. Arnold JA, Ranson SA, Abdalla SH. Azathioprine-associated acute myeloid leukaemia with trilineage dysplasia and complex karyotype: a case report and review of the literature. Clin Lab Haematol 1999;21:289-92.
35. Thalhammer-Scherrer R, Wieselthaler G, Knoebl P, Schwarzinger I, Simonitsch I, Mitterbauer G, et al. Post-transplant acute myeloid leukemia (PT-AML). Leukemia 1999;13:321-6.
36. Huebner G, Karthaus M, Pethig K, Freund M, Ganser A. Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation. Transplantation 2000;70:688-90.
37. Depil S, Lepelley P, Soenen V, Preudhomme C, Lai JL, Broly F, et al. A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation. Leukemia 2004;18:878.
38. Knipp S, Hildebrandt B, Richter J, Haas R, Germing U, Gattermann N. Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 2005;90:691-3.
39. Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener HC, et al. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Mult Scler 2006;12:363-6.
40. Menes M, Vakiani E, Keller CE, Ho EK, Colovai A, Nichols G, et al. The spectrum of myelodysplastic syndromes post-solid organ transplantation: a single institutional experience. Leuk Res 2007;31:59-65.
41. Park TS, Cheong JW, Song J, Lee KA, Lee SG, Kim J, et al. Acute erythroleukemia with der(1;7)(q10;p10) as a sole acquired abnormality after treatment with azathioprine. Cancer Genet Cytogenet 2008;186:58-60.
42. Yenson PR, Forrest D, Schmiegelow K, Dalal BI. Azathioprine-associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S-methyltransferase deficiency. Am J Hematol 2008;83:80-3.
43. Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum 1997;40:1580-6.
44. Ondrus D, Pribylincová V, Breza J, Bujdák P, Miklosi M, Reznícek J, et al. The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy. Int Urol Nephrol 1999;31:417-22.
45. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44.
46. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-45.
47. Nimer SD. Myelodysplastic syndromes. Blood 2008;111:4841-51.
48. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008;22:240-8.
49. Offman J, Opelz G, Doehler B, Cummins D, Halil O, Banner NR, et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 2004;104:822-8.
50. Marshall E. Preventing toxicity with a gene test. Science 2003;302:588-90.